STOCK TITAN
  1. Home
  2. Sec-filings
  3. IQV
  4. [Form 4] IQVIA HOLDINGS INC. Insider Trading Activity

IQVIA Holdings (NYSE: IQV) CEO exercises rights and trades common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ari Bousbib, Chairman, Chief Executive Officer and President of IQVIA Holdings Inc., exercised stock appreciation rights covering 156,206 shares of common stock on 2026-07-29 at an exercise price of $78.21 per share, from rights expiring on February 2, 2027. On the same date he sold an aggregate 106,279 shares of common stock in open-market transactions at weighted average prices of $247.10, $246.85, $246.08 and $244.78 per share, with individual trade prices ranging from $244.60 to $247.18 as described in the footnotes. He also disposed of 47,858 and 2,069 shares back to the issuer. Following these transactions, 543,302 shares of IQVIA common stock are held indirectly through the Orohena Trust.

Positive

  • None.

Negative

  • None.
Insider BOUSBIB ARI
Role See Remarks
Sold 106,279 shs ($26.09M)
Approx. gross sale proceeds $26.09M
Approx. exercise cost $12.22M
Type Security Shares Price Value
Exercise Stock Appreciation Right 156,206 $78.21 $12.22M
Exercise Common Stock F1 156,206 $78.21 $12.22M
Sale Common Stock F1, F2 4,465 $247.10 $1.10M
Sale Common Stock F1, F3 4,584 $246.85 $1.13M
Sale Common Stock F1, F4 44,039 $246.08 $10.84M
Sale Common Stock F1, F5 53,191 $244.78 $13.02M
Disposition Common Stock F1 47,858 $244.60 $11.71M
Disposition Common Stock F1 2,069 $247.00 $511K
holding Common Stock F6 -- -- --
Holdings After Transaction: Stock Appreciation Right — 0 shares (Direct); Common Stock — 835,941 shares (Direct); Common Stock — 543,302 shares (Indirect, By Trust)
Footnotes (6)
  1. F1. Represents the exercise of stock appreciation rights expiring on February 2, 2027.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.00 to $247.18, inclusive.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.70 to $247.05, inclusive.
  4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.58, inclusive.
  5. F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.60 to $245.60, inclusive.
  6. F6. Shares held in Orohena Trust.
Stock appreciation rights exercised 156,206 shares Exercise of Stock Appreciation Right into Common Stock on 2026-07-29 at $78.21 per share
Exercise price $78.21 per share Conversion of Stock Appreciation Right expiring on February 2, 2027
Shares sold 106,279 shares Aggregate common stock sales on 2026-07-29 across four S-coded transactions
Weighted average sale prices $247.10, $246.85, $246.08, $244.78 per share Prices for four sale blocks, with individual trades between $244.60 and $247.18
Shares disposed to issuer 47,858 shares at $244.60; 2,069 shares at $247.00 Two D-coded dispositions of common stock to issuer on 2026-07-29
Indirect trust holdings 543,302 shares Common stock held indirectly "By Trust" in Orohena Trust after reported transactions
Stock Appreciation Right financial
"Represents the exercise of stock appreciation rights expiring on February 2, 2027."
A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Disposition to issuer financial
"transaction_code_description": "Disposition to issuer""
indirect financial
"total_shares_following_transaction": "543302.0000", "ownership_type": "indirect""
By Trust financial
"nature_of_ownership": "By Trust""

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider activity did IQVIA Holdings (IQV) CEO Ari Bousbib report on 2026-07-29?
Ari Bousbib reported exercising 156,206 stock appreciation rights at $78.21 per share and related common stock transactions. The filing also details common stock sales, shares disposed back to the issuer, and substantial indirect holdings through the Orohena Trust.

How many IQV shares did Ari Bousbib acquire through stock appreciation rights for IQV?
He acquired 156,206 shares of IQVIA common stock by exercising stock appreciation rights at an exercise price of $78.21 per share. These rights were scheduled to expire on February 2, 2027, and were fully exercised, leaving no remaining balance under that award.

How many IQV shares did Ari Bousbib sell and at what prices in this Form 4 for IQV?
He sold a total of 106,279 shares of IQVIA common stock in multiple transactions. Weighted average prices were $247.10, $246.85, $246.08 and $244.78 per share, with individual sales occurring between $244.60 and $247.18 per share.

Did Ari Bousbib return any IQVIA (IQV) shares to the issuer in this filing?
Yes. He reported two dispositions to the issuer of IQVIA common stock: one for 47,858 shares at $244.60 per share and another for 2,069 shares at $247.00 per share, both coded as dispositions to issuer.

What IQVIA (IQV) shareholdings does Ari Bousbib report indirectly through a trust?
The filing shows an indirect holding of 543,302 shares of IQVIA common stock, noted as held “By Trust”. A footnote specifies these shares are held in the Orohena Trust, indicating trust-level ownership associated with the reporting person.

Were the IQV share sale prices in Ari Bousbib’s Form 4 simple or weighted averages?
The reported sale prices in Column 4 are weighted average prices for each transaction block. Footnotes explain that the underlying shares were sold in multiple trades within specified price ranges, from $244.60 up to $247.18 per share.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BOUSBIB ARI
(Last)(First)(Middle)
C/O IQVIA HOLDINGS INC.
2400 ELLIS ROAD
(Street)
DURHAM NORTH CAROLINA 27703
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/29/2026M156,206(1)A$78.21992,147D
Common Stock07/29/2026S4,465(1)D$247.1(2)987,682D
Common Stock07/29/2026S4,584(1)D$246.85(3)983,098D
Common Stock07/29/2026S44,039(1)D$246.08(4)939,059D
Common Stock07/29/2026S53,191(1)D$244.78(5)885,868D
Common Stock07/29/2026D47,858(1)D$244.6838,010D
Common Stock07/29/2026D2,069(1)D$247835,941D
Common Stock543,302IBy Trust(6)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Appreciation Right$78.2107/29/2026M156,20602/02/202002/02/2027Common Stock156,206$78.210D
Explanation of Responses:
1. Represents the exercise of stock appreciation rights expiring on February 2, 2027.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.00 to $247.18, inclusive.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.70 to $247.05, inclusive.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.58, inclusive.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.60 to $245.60, inclusive.
6. Shares held in Orohena Trust.
Remarks:
Chairman, Chief Executive Officer & President Power of Attorney
/s/ Abigail Jeck, Attorney-in-Fact for Ari Bousbib07/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR